Published in
Elsevier, Multiple Sclerosis and Related Disorders, (44), p. 102323, 2020
DOI: 10.1016/j.msard.2020.102323
Links
Tools
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
Journal article published in 2020 by
Matteo Lucchini 
,
Assunta Bianco ,
Paola Del Giacomo,
Chiara De Fino ,
Viviana Nociti ,
Massimiliano Mirabella
,
Assunta Bianco ,
Paola Del Giacomo,
Chiara De Fino ,
Viviana Nociti ,
Massimiliano Mirabella
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 